Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | KCNA5 | P22460 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
| ▸ | SRC | P12931 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9068085 | 0.80 | SMN1; SMN2 (0.47) | ALDH1A1KDM4EATML3MBTL1 | |
| SCHEMBL28201839 | 0.79 | ALDH1A1 (0.59) | ALDH1A1MTNR1AMTNR1B | |
| SCHEMBL27725242 | 0.79 | LMNA (0.50) | ALDH1A1KDM4EKCNA5LMNAHPGD | |
| SCHEMBL8755345 | 0.78 | ALDH1A1 (0.38) | ALDH1A1KDM4EKCNA5LMNAHPGD | |
| SCHEMBL5858432 | 0.78 | TGM2 (0.45) | ALDH1A1KDM4EKCNA5LMNAHPGD | |
| SCHEMBL10634749 | 0.77 | TGM2 (0.44) | ALDH1A1KDM4EKCNA5LMNAPOLB | |
| SCHEMBL11063512 | 0.77 | KMT2A (0.41) | TGFBR1ALDH1A1KDM4ELMNAHPGD | |
| Diphenylamine SCHEMBL11692048 | 0.76 | ALDH1A1 (0.44) | TGFBR1ALDH1A1KDM4ELMNAHPGD | |
| SCHEMBL10000908 | 0.76 | ALDH1A1 (0.39) | TGFBR1ALDH1A1KDM4EKCNA5LMNA | |
| SCHEMBL18329135 | 0.75 | MEN1 (0.47) | ALDH1A1KDM4EKCNA5LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160369017-A1 | CURABLE COMPOSITION, POLYMER FUNCTIONAL CURED PRODUCT, WATER-SOLUBLE ACRYLAMIDE COMPOUND, AND METHOD FOR MANUFACTURING SAME | FUJIFILM CORPORATION (JP) | 2016-12-22 | — | — | US | disclosed |
| US-20160369017-A1 | CURABLE COMPOSITION, POLYMER FUNCTIONAL CURED PRODUCT, WATER-SOLUBLE ACRYLAMIDE COMPOUND, AND METHOD FOR MANUFACTURING SAME | FUJIFILM CORPORATION (JP) | 2016-12-22 | — | — | US | disclosed |
| US-5787686-A | CONTAINING WATER INSOLUBLE AGRICULTURE PESTICIDE | THE DOW CHEMICAL COMPANY (US) | 1998-08-04 | — | — | US | disclosed |
| US-5753766-A | Amphipathic graft copolymers and copolymer compositions and methods of making | THE DOW CHEMICAL COMPANY (US) | 1998-05-19 | — | — | US | disclosed |
| US-5753248-A | Amphipathic graft copolymer pesticide formulation compositions and methods of their use | THE DOW CHEMICAL COMPANY (US) | 1998-05-19 | — | — | US | disclosed |
| EP-0766705-B1 | PREPARATION OF AMPHIPATHIC GRAFT COPOLYMERS, COMPOSITIONS THEREOF, AND METHODS OF THEIR USE | DOW CHEMICAL CO (US) | 1998-05-13 | — | — | EP | disclosed |
| US-5693716-A | Amphipathic graft copolymers and copolymer compositions and methods of making | THE DOW CHEMICAL COMPANY (US) | 1997-12-02 | — | — | US | disclosed |
| CN-1159199-A | Novel amphipathic graft copolymers, their prepn., compositions thereof and methods of their use | DOW CHEMICAL CO (US) | 1997-09-10 | — | — | CN | disclosed |
| EP-0766705-A1 | PREPARATION OF AMPHIPATHIC GRAFT COPOLYMERS, COMPOSITIONS THEREOF, AND METHODS OF THEIR USE | THE DOW CHEMICAL COMPANY (US) | 1997-04-09 | — | — | EP | disclosed |
| WO-1996000251-A1 | NOVEL AMPHIPATHIC GRAFT COPOLYMERS, THEIR PREPARATION, COMPOSITIONS THEREOF, AND METHODS OF THEIR USE | THE DOW CHEMICAL COMPANY (US) | 1996-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160369017-A1 | CURABLE COMPOSITION, POLYMER FUNCTIONAL CURED PRODUCT, WATER-SOLUBLE ACRYLAMIDE COMPOUND, AND METHOD FOR MANUFACTURING SAME | MRPL21, WDR1, CCNT1 | TGFBR1 154/4885ALDH1A1 66/4885KDM4E 2714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.